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Abstract
The demand for cobalamin (vitamin B12) and folate is increased during pregnancy, and deficiency during pregnancy may lead to complications and adverse
outcomes. Yet, the status of these micronutrients is unknown in many populations. We assessed the concentration of cobalamin, folate and their functional
biomarkers, total homocysteine (tHcy) and methylmalonic acid (MMA), in 561 pregnant women enrolled in a community-based randomised controlled trial
in Bhaktapur, Nepal. Plasma concentrations of cobalamin, folate, tHcy and MMA were measured and a combined indicator of vitamin B12 status (3cB12)
was calculated. We report mean or median concentrations and the prevalence of deficiency according to commonly used cut-offs, and assessed their asso-
ciation with indicators of socio-economic status, and maternal and dietary characteristics by linear regression. Among the women at gestational week less
than 15, deficiencies of cobalamin and folate were seen in 24 and 1 %, respectively. Being a vegetarian was associated with lower plasma cobalamin, and a
higher socio-economic status was associated with a better micronutrient status. We conclude that cobalamin deficiency defined by commonly used cut-offs
was common in Nepalese women in early pregnancy. In contrast, folate deficiency was rare. As there is no consensus on cut-off points for vitamin B12
deficiency during pregnancy, future studies are needed to assess the potential functional consequences of these low values.
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Introduction
Cobalamin and folate, also known as vitamin B12 and vitamin
B9, respectively, are crucial for rapid cell division and anabolic
processes, as well as for the synthesis of DNA(1). In addition,
both have essential roles in the central nervous system and in
the methylation cycle(2,3), and deficiency in either micronu-
trient can lead to megaloblastic anaemia(4,5). Overt deficiency
and suboptimal status of these two vitamins are major public
health concerns affecting a large number of people across all
ages worldwide(6–8).
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During pregnancy and lactation, women have a higher risk
of deficiency due to an increased demand for vitamin B12
and folate(9–11). In a meta-analysis including fifty-seven studies
from across the globe, it was estimated that one-fourth of all
pregnant women were cobalamin-deficient across all trimesters
of pregnancy(9). In the four studies from the Indian subcontin-
ent included in this meta-analysis, 32 % of women were defined
as cobalamin-deficient in their first trimester, and 64 % in the
second trimester. Both maternal vitamin B12 deficiency and fol-
ate deficiency have been associated with an increased risk of
complications and poorer outcomes in pregnancy(12–20) as well
as long-term consequences such as impaired postnatal growth
and cognitive development(21–25).
Total homocysteine (tHcy) and methylmalonic acid (MMA)
are functional biomarkers of vitamin B12 status, both increas-
ing with decreasing cobalamin concentration. While MMA is a
specific indicator of cobalamin, tHcy is influenced by other
factors, in particular folate status(17,26). A combined indicator
of vitamin B12 has been proposed which includes both direct
and functional biomarkers, namely cobalamin, MMA, tHcy
and holotranscobalamin(27).
The most direct causes of vitamin B12 and folate deficiency
are related to the diet and to malabsorption(28). Biologically
active cobalamin is only found in animal-derived foods, while
folate is most abundant in green leafy vegetables, legumes and
some fruits. Therefore, vegetarians are at higher risk of a vitamin
B12 deficiency(28,29), and populations consuming diets low in
fresh fruits, vegetables and cereals are at greater risk of folate
deficiency(30). A social gradient in vitamin status has also been
demonstrated, with an increasing level of deficiency associated
with lower socio-economic status (SES)(29,31,32).
Evidence on the prevalence of vitamin B12 or folate defi-
ciency is often derived from non-representative surveys with
relatively small sample sizes. In Nepal, there is no population-
based prevalence data evaluating vitamin B12 and folate status
among pregnant women. However, in non-pregnant women
aged 15–49 years, the Nepal National Micronutrient Status
Survey 2016 reported a folate deficiency in 5 % of the women
(erythrocyte folate <226⋅5 nmol/l)(33). Other studies suggest a
high prevalence of cobalamin deficiency in Nepal among non-
pregnant(34) and pregnant women(35,36), while folate deficiency
was uncommon(34–36). However, these studies do not represent
recent population data, as most of these studies were performed
before 2001. In the present study, we aimed to assess the vitamin
B12 and folate status using plasma concentrations of cobalamin,
folate and their functional biomarkers, namely tHcy and MMA,
among a community-based population of women in early preg-
nancy from the municipality of Bhaktapur, Nepal. We also
aimed to assess investigate both direct and functional biomar-
kers of vitamin B12 and folate in relation to indicators of SES,
and maternal and dietary characteristics.
Methods
Study site and population
The study site, Bhaktapur municipality and its surrounding
area, lies nearly 15 km east of the capital city of Nepal,
Kathmandu. Bhaktapur is an ancient and well-preserved city,
settled primarily by the Newar ethnic group. According to
the last census in 2011, nearly 82 000 inhabitants resided in
Bhaktapur municipality. The population is a predominantly
agriculture-based semi-urban community. Many households
depend on small business or other daily work and services
for additional income. Domestic migrant workers from nearby
districts with diverse ethnic backgrounds work seasonally in
carpet factories and brick industries within Bhaktapur.
The area is characterised by warm and temperate climate with
a hot and wet summer, and a cold and dry winter. The average
annual temperature and rainfall are 17⋅9 °C and 1583 mm,
respectively(37). While rice is the staple food throughout the
year, inhabitants mostly consume locally grown food with vege-
tables and fruit intake varying in relation to the season. Intake of
non-vegetarian foods is common during cultural celebrations
and feasts. Factors such as availability of food, varying food
prices and workload also determine the food intake of residents.
Eligible women for the study were screened from the com-
munity as well as from the study site hospital, the Siddhi
Memorial Hospital for women and children, which is a non-
governmental community hospital located in Bhaktapur.
Study design and study sample
Data for the present study were gathered from the baseline
assessment of an ongoing community-based, individually ran-
domised, double-blinded placebo-controlled trial that intended
to assess the effects of daily vitamin B12 supplementation
from early pregnancy (<15 weeks of gestation) up to 6 months
post-partum on child growth and neurodevelopment. Details
of the main study have been published elsewhere(38). In
brief, 800 pregnant women aged 20–40 years, residing in the
Bhaktapur municipality and nearby areas, not intending to
leave their current settlement for at least 2 years, were targeted
for inclusion in the study. Additional inclusion criteria were
body mass index (BMI) between 18⋅5 and 30, not chronically
ill and under treatment, and no severe anaemia. Vitamin B12
has not yet been recommended for universal use during preg-
nancy in Nepal, but often medications or nutrient supplements
containing vitamin B12 are prescribed for pregnant women.
Women were excluded if they were already taking nutrient sup-
plements containing vitamin B12.
If they had not started taking it before enrolment, folic acid
was provided to all participants during the first 2 months of
pregnancy, and iron and calcium after gestational week 12,
as per national guidelines from the Government of Nepal.
For the present study, the results of blood sample analyses
were available for the first 561 pregnant women enrolled
between April 2017 and March 2020.
Data collection
Socio-demographic information was collected at enrolment
through interview. Information on education was categorised
into illiterate or primary level (education up to grade 5), sec-
ondary level (grade 6–12) and Bachelor’s level or above.




















































































































or Gurung/Rai/Magar/Tamang. All other ethnic groups such
as Chaudhari, Madhesi, Muslims and Dalit were categorised as
others. The Newar ethnic group was chosen as a reference
group as it constituted the majority among our study partici-
pants (∼80 %). Gestational week was estimated from the
date of the first day of the last menstrual cycle (LMP method)
and ascertained by ultrasound scans. Family type was defined
as nuclear if only the parents and the child were living
together, and joint or other, if more family members lived in
the household. Parity was categorised as primi (having one
child), and multi (having two or more children). The mothers
were also asked about their age, as well as current smoking
and alcohol consumption habits. Occupation was categorised
as housewives, working in services (both private and govern-
mental), owning a (small-scale) business, daily wage earners
and others which includes those working in agriculture and
without formal employment. We asked the mothers if they
had or have had any pregnancy-related complaint, such as nau-
sea/vomiting, appetite loss, abdominal pain and dizziness. We
dichotomised this variable as complaints and no complaints.
Weight and height were measured using an electronic weigh-
ing scale and stadiometer (both seca, Germany). BMI was cal-
culated as body weight (in kg) divided by the square of body
height (in m).
Blood sampling and biochemical analyses
At enrolment, i.e. before any supplement had been given, 3 ml
of blood were collected into vials containing EDTA as anti-
coagulant for the study purpose at the field office laboratory.
The blood samples were centrifuged at approximately 700 g
at room temperature for 10 min; plasma was then separated
and collected into three cryovials while cells were transferred
separately into another cryovial. All cryovials were labelled
and then stored and transported at a maximum of −72 °C
in liquid nitrogen, dry ice and ultra-freezers until analysis.
Following blood draw, haemoglobin concentration was ana-
lysed immediately using HemoCue (Vedbæk, Denmark), cali-
brated based on manufacturer’s guidelines. Concentrations
of plasma cobalamin and folate were assessed by microbio-
logical assays based on a colistin sulphate-resistant strain of
Lactobacillus leichmannii(39) and chloramphenicol-resistant strain
of Lactobacillus casei (40), respectively, adapted to a microtiter for-
mat performed by a robotic workstation. Concentrations of
the functional biomarkers, plasma tHcy and MMA were ana-
lysed using gas chromatography-tandem mass spectrometry
based on methylchloroformate derivatisation(41). For both
cobalamin and folate, the within-day coefficient of variation was
4 %, for tHcy 1 % and MMA 1–4 %. The between-day coeffi-
cient of variation was 5 % for cobalamin and folate, 2 % for
tHcy and 3–8 % for MMA. Plasma concentrations of cobalamin,
folate, tHcy and MMA were analysed at Bevital AS, Bergen,
Norway (www.bevital.no).
Definitions of cut-offs
The cut-off value adopted for low cobalamin was <150 pmol/
l(42) and for low folate <10 nmol/l(43). In addition, we report
low cobalamin with a cut-off <250 pmol/l as suggested to indi-
cate inadequacy(44). For high tHcy, we used the cut-off value of
>10 μmol/l(45), and for high MMA >0⋅26 μmol/l(35,42,46). For
anaemia, we report both the commonly used cut-off value of
11 g/dl for haemoglobin, as well as the altitude-adjusted
(1400 m) cut-off value of <11⋅3 g/dl(47,48).
We calculated a combined indicator of vitamin B12 status
(3cB12) according to Fedosov et al.(27), as log(B12/Hcy*MMA),
adjusted with the folate and age factor given by Fedosov. For
the purpose of the present study, we categorised 3cB12 as
<−0⋅5 (vitamin B12 deficiency) and ≥−0⋅5 (vitamin B12
adequacy).
Statistical analyses and justification of sample size
As we used data from an existing study, the sample size was
set at 561 women. With this sample size, we could identify
the prevalence of a certain nutrient deficiency with a 95 %
confidence interval (CI) of not more than ±4 percentage
points around a given estimate. In this calculation, we assumed
a prevalence of 50 % as this is the most conservative
approach; a higher or lower prevalence would result in a higher
precision of the estimate.
All data were double entered in a local database and discrep-
ancies and completeness were checked by the data entry super-
visor. Data were analysed using Stata, version 16(49). For
describing the study sample characteristics, we report mean
and standard deviation (SD), median and interquartile range
(IQR), or percentage, as appropriate.
We used boxplots to describe the distribution of cobalamin,
folate, tHcy, MMA, the combined indicator of cobalamin
(3cB12) and haemoglobin, where a red line represents the
respective cut-off value in each boxplot. We depicted the rela-
tion between cobalamin and its functional biomarkers (tHcy
and MMA) using fractional-polynomial prediction plots.
For all indicators used, we built separate bivariable linear
regression models with all variables included in Table 1 as
independent variables. Folate, tHcy and MMA were not nor-
mally distributed (skewness >2) and therefore log-
transformed. For the multivariable linear model, we followed
the purposeful selection procedure described by Hosmer
et al.(50). If the variables were significantly associated with
the outcome in the bivariable models on the basis of a
P-value < 0⋅2, they were entered into a multivariable linear
regression model simultaneously. Then, we removed the vari-
able with the highest P-value. This step was repeated until all
significant variables (P < 0⋅05) were retained in the saturated
model. All variables not in the saturated model were then
entered again, one by one, and retained if they now were sig-
nificant (P< 0⋅05).
Ethical considerations
The main study was conducted according to the guidelines laid
down in the Declaration of Helsinki and all procedures involv-
ing human subjects were approved by the Nepal Health
Research Council (NHRC, #253/2016) and the Regional




















































































































Western Norway (2016/1620/REK vest). The study is also
registered at clinicaltrials.gov (NCT03071666), and under the
Universal Trial Number (U1111-1183-4093). At the imple-
mentation site in Bhaktapur, informed written consent was
obtained from eligible and willing pregnant women prior to
enrolment.
Results
Characteristics of the study cohort
The characteristics of the 561 women included in the present
study are shown in Table 1. The women had a mean age of
27⋅5 years (±3⋅8 years), a mean BMI of 23⋅7 (±3⋅0) and a
mean gestational week of 11 (±2⋅9 weeks). Less than 2 % of
the enrolled women were vegetarian, and less than half of
the vegetarian women reported eating eggs. The current preg-
nancy was the first for 42 % of the women. Twenty-two
percent of the women had completed education up to
Bachelor’s level or above, while nearly 8 % of the mothers
were either illiterate or had ended their education before 6th
grade.
Medications and health-related complaints
At the time of study enrolment, 69 % of the women had
already started folic acid supplementation before the study.
Out of 253 participants enrolled at or after gestation week
12, 86 (34 %) had already started iron supplementation as
per national guidelines. Approximately 12 % of the women
were taking over-the-counter multivitamins or nutrient supple-
ments without vitamin B12 at the time of enrolment. One in
five of the participants were taking other medications, such as
anti-emetic drugs. Less than 1 % of the women were taking
antibiotics at the time of enrolment. Plasma cobalamin con-
centrations did not differ between those who had started
folic acid, iron or multivitamin supplementation at the time
of enrolment. However, the mean plasma folate concentration
was higher among those taking multivitamins compared with
those who were not (78 nmol/l v. 62 nmol/l; t-test, P < 0⋅05).
Approximately one in three women reported pregnancy-
related complaints. Nausea and vomiting were the most com-
mon complaints (reported by 26 % of all the mothers),
followed by loss of appetite (6 %), lower abdominal pain
(3 %) and dizziness/vertigo (1 %).
Plasma biomarker profile
The distribution for plasma concentrations of cobalamin,
folate, tHcy, MMA and haemoglobin of all study participants
(n 561) is illustrated in Fig. 1, and mean plasma concentrations
are presented in Table 2. Approximately 24 % of the pregnant
women were found to be cobalamin-deficient (plasma cobala-
min <150 pmol/l), while the combined indicator (3cB12) indi-
cated a vitamin B12 deficiency among 16 % of the women.
One percent of the participants were folate-deficient, and
16 % were anaemic.
Association of cobalamin with functional biomarkers
Fig. 2 illustrates the relation between plasma cobalamin v. tHcy
(Panel a) and cobalamin v. MMA (Panel b). Both functional
markers show a negative association with plasma cobalamin
which appears to be close to linear.
Factors associated with cobalamin and folate
All results from the linear regression analyses are presented in
Supplementary Tables S1–S5 of the supplementary material.
Fig. 3 illustrates the standardised coefficients (beta) of the
variables retained in the final multivariable models.
In the final multivariable model, being a vegetarian was
associated with a lower cobalamin concentration (adjusted
coefficient −66⋅6; 95 % CI −123⋅9, −9⋅37). The same asso-
ciation was observed for the functional markers, both of
which were on average higher in the vegetarian group
Table 1. Socio-economic, maternal and dietary characteristics of 561
pregnant women (<15 weeks of gestation) living in Bhaktapur, Nepal
Characteristics Mean (SD) Number (%)
Age (years) 27⋅5 (3⋅8)
Body Mass Index (kg/m2) 23⋅7 (3⋅0)
Vegetarian mothersa 7 (1⋅7)
Gestational weekb 11 (2⋅9)
Parity (%)
Primi 237 (42⋅2)
Second gravida or more 324 (57⋅8)
Educational level (years)
















30 000 (20 000–50 000)
Family type
Nuclear 192 (34⋅2)












Current Smoker 2 (0⋅4)
Alcohol consumptionc
No alcohol 309 (55⋅1)
Once a month or less 208 (37⋅1)
Few times a month 38 (6⋅8)
More than once a week 6 (1⋅0)
aN 406, vegetarian was defined as not eating meat and eggs.
b Assessed by the last menstrual period (LMP) method and confirmed by ultrasound
scan.




















































































































compared with those eating meat (MMA: 0⋅48; 95 % CI 0⋅04,
0⋅92; tHcy: 0⋅57; 95 % CI 0⋅35, 0⋅79). Having reported
pregnancy-related complaints was associated with a higher
cobalamin concentration (22⋅5; 95 % CI 7⋅39, 37⋅6). Being
affiliated with the ethnic grouping of Gurung/Rai/Magar/
Tamang was associated with higher cobalamin compared
with the Newar ethnic group (54⋅8; 95 % CI 27⋅4, 82⋅2).
Although significant in the bivariable analyses, maternal age,
BMI, gestational week, maternal educational level and the fre-
quency of alcohol consumption were no longer significantly
associated with cobalamin in the final model (P> 0⋅05).
For folate, being affiliated with the Gurung/Rai/Magar/
Tamang ethnic group was associated with a lower plasma con-
centration (−0⋅31; 95 % CI −0⋅49, −0⋅13). Age (0⋅02; 95 %
CI 0⋅006, 0⋅03), gestational week (0⋅02; 95 % CI 0⋅002,
0⋅04) and monthly income (0⋅001; 95 % CI 0⋅0001, 0⋅002)
were positively associated with folate status, while having
two or more children was associated with a lower mean folate
concentration compared with having only one child (−0⋅18;
95 % CI −0⋅30, −0⋅06). Although significant in the bivariable
analyses, maternal educational level, occupation group, family
type and frequency of alcohol consumption were no longer
significantly associated with folate.
Discussion
In this cross-sectional study investigating cobalamin and
folate status among pregnant Nepalese women of gestational
age 5–15 weeks, 24 % women were cobalamin-deficient,
and 1 % were folate-deficient according to commonly used
cut-offs for deficiency.
The status of vitamin B12 among pregnant women in their
first trimester in the Bhaktapur district, Nepal, has not previ-
ously been assessed in a community-based setting. Among two
earlier studies suggesting a high prevalence of cobalamin defi-
ciency among pregnant women, one was hospital based(35),
and another was based in a district in the Southern plains of
Nepal(36). Our study suggests that one in four pregnant
women in their first trimester was vitamin B12-deficient
when using plasma cobalamin as the sole marker for status.
In resource-poor settings, diets are often plant-based and
low in animal-derived foods due to factors such as high
cost, lack of accessibility, availability and impact of cultural
or religious beliefs(28). As the main source of vitamin B12 is
animal-derived food items, populations in resource-poor set-
tings are especially vulnerable to vitamin B12 deficiency. In
similar settings, seasonal shortages of vegetables and fruits,
or replacement of these food with low-nutrient dense foods
such as polished white rice due to low economic status, has
Fig. 1. Distribution of plasma cobalamin, folate, total homocysteine (tHcy), methylmalonic acid (MMA), a combined indicator of vitamin B12 status (3cB12) and
haemoglobin among 561 pregnant women (<15 weeks of gestation) from Bhaktapur, Nepal. Boxplot graphs are used to indicate the median (middle line in the
box), the IQR (box around the 25th and 75th percentile), the upper and lower extreme values (values within 1⋅5 times the IQR; the whiskers), as well as outliers
(dots outside the whiskers). Reference cut-offs used in the present study are added to these graphs (red dashed lines).
Table 2. Mean concentrations of plasma cobalamin, folate and their
functional biomarkers, and haemoglobin for 561 pregnant women (<15








Cobalamin (pmol/l) 204⋅5 (78⋅5) <150 24⋅4 (137)
<250 77⋅3 (434)
Folate (nmol/l) 63⋅6 (53⋅8) <10 <1 (2)
Total homocysteine
(μmol/l)
6⋅4 (2⋅4) >10 7⋅7 (43)
Methylmalonic acid
(μmol/l)




0⋅10 (0⋅60) <−0⋅5 16⋅0 (90)
Haemoglobin (g/dl) 12⋅4 (1⋅1) <11⋅3 16⋅0 (90)
<11 10⋅5 (59)
a Suboptimal concentration is defined as value above the chosen cut-off for total





















































































































been described as a cause of short-term folate deficiency(9).
Typically, such deficiency can be relieved quickly without
any adverse health effects; however, for women in their first
trimester, even short-term shortages of food items high in fol-
ate have been shown to severely affect the foetus(51). In the
hills and mountains of Nepal, common household diets
were mostly deficient in vitamin B12 and calcium(52). This
could explain the relatively high prevalence of cobalamin defi-
ciency shown by our study.
Only 2 % of the participants reported to be vegetarian. In
agreement with previous studies(29,53–55), these pregnant
women were found more likely to have poor vitamin B12 sta-
tus. However, our findings demonstrate that cobalamin defi-
ciency was not limited to vegetarian women. It has been
suggested that even among individuals who do not identify
as being vegetarian, consumption of animal-derived food/
meat might be limited due to affordability and religious
beliefs(34,54,56).
Our findings suggest that less than 1 % of the pregnant
women were folate-deficient. This is in line with other studies
showing that folate deficiency was not common in Nepal, nei-
ther in adults(34,35,36) nor in children(31,53,57,58). The adequate
folate status may be attributed to ongoing folic acid supple-
mentation during pregnancy as part of the national nutrition
programme, as well as a generally high consumption of
foods rich in folate, such as green leafy vegetables(59).
Although food intake varies according to the season in this
population, we did not see a clear seasonal trend in folate
Fig. 2. Association of cobalamin with (a) total homocysteine (tHcy) and (b) methylmalonic acid (MMA) among 561 pregnant women (<15 weeks of gestation) from
Bhaktapur, Nepal, using fractional-polynomial prediction plots. The line indicates the predicted mean, and the grey area depicts the 95 % confidence interval. Values
for cobalamin are restricted to the 1st to 99th centile.
Fig. 3. Factors associated with plasma concentrations of cobalamin, folate, total homocysteine (tHcy), methylmalonic acid (MMA) and a combined indicator of vita-
min B12 status (3cB12) among 561 pregnant women (<15 weeks of gestation) from Bhaktapur, Nepal. Displayed are standardised coefficients (beta) with 95 % con-
fidence intervals from multivariable linear regression models. Reference categories are non-vegetarian, no health-related complaints, the ethnic group Newar, parity




















































































































concentration according to timing of the blood draw (data not
shown). In our study, two out of every three participating preg-
nant women had already begun folic acid supplementation as per
national guidelines before the time of enrolment. For some
women, high plasma folate concentration may be explained by
the folate/methyl-trap hypothesis related to vitamin B12 defi-
ciency, intake of oral supplements shortly before blood sampling,
or high consumption of foods rich in folate(44,60).
In addition to the direct measures of cobalamin status, we
also assessed the functional biomarkers tHcy and MMA(61–65).
There was an inverse association between plasma cobalamin
concentration and both tHcy and MMA concentration, which
has also been described previously(61). In our sample, the preva-
lence of abnormal values was lower for tHcy (7 %) and higher
for MMA (33 %) compared to cobalamin (24 %). Circulating
tHcy levels are dependent on the availability of both cobalamin
and folate, while MMA is not affected by folate status(61). Folate
deficiency was rare in our study participants. In addition, other
studies undertaken in Nepal and India have demonstrated that
tHcy was not associated with dietary intake or vitamin B12
supplementation in pregnant women(21,66). Notably however,
in the Indian study, vitamin B12 supplementation of the
mothers reduced plasma tHcy concentrations in their infants
at 6 weeks after birth(66). This further supports evidence sug-
gesting that tHcy may not be a good indicator of vitamin B12
status during pregnancy. MMA is considered a more specific
marker of cobalamin function(46,67) and may help explain the
differences in prevalence that we observed. However, MMA
might have been altered to a larger extend by intestinal bacterial
overgrowth and infection(44). We did not have data to support
this. To increase the precision of diagnosing cobalamin defi-
ciency, Fedosov et al.(27) suggested the use of an indicator com-
bining several biomarkers of vitamin B12, with additional
adjustment for age and folate status. Using their formula for
the combined cobalamin indicator (3cB12), the prevalence of
cobalamin deficiency was 16 % in our study sample. A lower
prevalence of low vitamin B12 status measured by the 3cB12
indicator (47 %) compared with plasma vitamin B12 (<148
pmol/l) (63 %) has also been reported in a group of pregnant
women at 12 weeks of gestations in India(68). However, to
our knowledge, the use of the combined indicator is yet to be
validated among pregnant women and reasons for the discrep-
ancy between indicators remain unclear.
A deficiency of cobalamin and folate may result in anaemia,
as both are required for erythropoiesis(4,5). In our study, 16 %
of the pregnant women were anaemic according to a haemo-
globin cut-off at 11⋅3 g/dl (altitude-adjusted) and 10⋅5 % with
a cut-off at 11 g/dl. The Nepal Micronutrient Status Survey
2016 suggested a higher prevalence of anaemia among preg-
nant women of nearly 27 % when using 11 g/dl of haemoglo-
bin as cut-off(33). The higher prevalence in the national sample
could be attributed to differences in gestational age, maternal
age and sampling location. In the present study, cobalamin
deficiency was not associated with anaemia, in concurrence
with an earlier study performed in the same setting among
non-pregnant women(34).
In our study, pregnancy-related complaints were associated
with a higher mean concentration of plasma cobalamin. The
interpretation of this observation is hindered by the non-
specific categorisation of all complaints into a single group.
Nonetheless, the finding appears somewhat counterintuitive,
as lower food intake and subsequently lower cobalamin status
would be expected to occur as a result of pregnancy-related
complaints such as vomiting and nausea. However, Nepali
women could have taken ready-made and fortified foods to
compensate the potential nutrient loss due to hyperemesis
gravidum. We did not adjust the analysis for dietary intake
and thus, cannot confirm this.
Higher SES was associated with better cobalamin and folate
status in our analysis; this is in line with findings from a study of
infants living in the same area(31) and has been repeatedly docu-
mented in other studies(28). Diets of populations with a low SES
are typically low in vitamin B12, due to higher prices and lower
availability of animal-derived foods. These populations are also
characterised by a higher disease burden, which can increase
nutrient requirements and impair the nutrient absorption(28).
Although Smith(69) states that differences in food intake
might better be described by means of income than cultural
restrictions, in our study, ethnic affiliation was consistently asso-
ciated with vitamin B12 and folate status, even when other indi-
cators of SES were included in the regression models. This
could indicate that in addition to differences in SES and thus
economic opportunities and access to health care, cultural prac-
tices which indicate a more varied diet and/or a more frequent
consumption of non-vegetarian diets could be important.
Strengths and limitations
The key strength of the present study is the comprehensive
characterisation of a large community-based cohort of
women sampled in early pregnancy. In addition, standard pro-
cedures were followed for blood sample collection, storage and
transfer, ensuring optimal cold chain, and state-of-the-art
biochemical methods were used to estimate biomarker con-
centrations. During pregnancy, cobalamin and folate require-
ments in the body increase; however, unfortunately, we did
not have data on dietary intake at the time point of enrolment.
To our knowledge, there are no specific, universally accepted
cut-off values for markers of vitamin B12 in early pregnancy.
It has been shown that concentrations of B12 biomarkers
decline during pregnancy, among others due to hemodilution.
However, different cut-off during pregnancy have not been
agreed upon, and cut-offs for the general population are com-
monly used. This is seen in a recent meta-analyses including
twelve studies during the first trimester, where eight of
the studies used cut-offs between 148 and 156 pmol/l(9).
The increase in plasma volume during pregnancy is not
expected to start before 6–10 weeks(70), and thus, the effect
of hemodilution on the prevalence of low B12 in participants
of the present study, measured on average at 11 weeks of
gestation, is expected to be minimal.
Conclusion
The prevalence of cobalamin deficiency in our study popula-




















































































































Nepal, was 24 %. In contrast, folate deficiency was rare. In
light of the high levels of cobalamin deficiency observed in
the present study, future studies are needed to assess the
potential functional consequences of suboptimal maternal
cobalamin status such as complications and adverse outcomes
in pregnancy as well as long-term outcomes such as impaired
postnatal growth and cognitive development.
Supplementary material
The supplementary material for this article can be found at
https://doi.org/10.1017/jns.2021.53.
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